OpenVSafe by OpenVAERS
Search V-safe

8N7-33795-82187

3 vaccinations 2 coded responses 4 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
12-15
ZIP prefix
038 / NH
Registered
2021-12-01
Relationship
Child or adolescent in my care
Guardian
BJ6-15605-96097
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-07-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-08-18
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-01
    Registered in v-safe
  4. 2022-02-16
    Survey response — 6 months, dose 2, dependent
    MedDRA: Nasal congestion, Oropharyngeal pain, Respiratory tract congestion, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school
    Free text: Sore throat, stuffy nose, congested. Home Covid test came back positive.
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-08-01
    Dose 3 — Pfizer-BioNTech
  6. 2022-08-18
  7. 2022-10-31
  8. 2023-01-30
    Survey response — 6 months, dose 3, dependent
    MedDRA: Headache, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-07-27Pfizer-BioNTech No
22021-08-18Pfizer-BioNTech No
32022-08-01Pfizer-BioNTech No

Free text

Release 11 — 6 months, dose 2, dependent

2022-02-16

Symptoms: Sore throat, stuffy nose, congested. Home Covid test came back positive.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test positive · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release